Skip to main content
Erschienen in: BMC Women's Health 1/2006

Open Access 01.12.2006 | Research article

A descriptive study of variables associated with obtaining nipple aspirate fluid in a cohort of non-lactating women

verfasst von: Kimberly A Baltzell, Margaret Wrensch, Jennette D Sison

Erschienen in: BMC Women's Health | Ausgabe 1/2006

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

The search for biologic endpoints and biomarkers in the study of breast cancer risk assessment and risk reduction strategies has led to an interest in obtaining cytologic information and other biomarkers from nipple aspirate fluid (NAF).

Methods

This descriptive study examined factors associated with an increased ability to obtain NAF in a cohort of 3043 women between the ages of 15 and 89 years of age. The majority of women were between the ages of 30–49 (N = 1529/50.2%). Variables examined in relation to obtaining fluid include: age, marital status, age at menarche, menopausal status, a history of pregnancy, a history of breast-feeding, estrogen use, oral contraceptive use, endocrine disorders and tranquilizer use.

Results

On average, women from whom breast fluid was obtained were younger than women from whom breast fluid was attempted but not obtained (mean = 41.9 years versus 46.5 years, p < 0.0001). In unadjusted and age-adjusted comparisons, being married, a history of pregnancy, younger age at menarche (12 years of age or younger), tranquilizer use, oral contraceptive pill (OCP) use and endocrine problems were associated with an increased ability to obtain breast fluid. Post-menopausal status and exogenous estrogen use were associated with a decreased ability to obtain breast fluid. After age-adjustment, oral contraceptive use was no longer significantly associated with an increased ability to obtain fluid and post-menopausal status was no longer associated with a decreased ability to obtain breast fluid. After multivariate adjustment, age, being married, a history of pregnancy, tranquilizer use and a history of endocrine problems remained positively associated with the ability to obtain breast fluid. In addition, menopausal women who took estrogen were less likely to yield fluid than premenopausal women.

Conclusion

Four variables (being married, history of pregnancy, tranquilizer use and endocrine disorders) remained positively associated with the ability to obtain NAF in all analyses. A younger age was consistently associated with a greater ability to obtain NAF in this and other studies.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1472-6874-6-15) contains supplementary material, which is available to authorized users.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

KB conceived of the study and set up the design and coordination of the research team. She also reviewed and interpreted all statistical analyses and drafted the original manuscript. MW participated in the study design and helped to draft the manuscript, including reviewing data analysis and providing assistance with revisions. JS performed statistical analyses. All authors have read and approved the final manuscript.
Abkürzungen
BMI
Body mass index
BSO
Bilateral salpingo-oophorectomy
BSE
Breast self-examination
CBE
Clinical breast exam
MRI
Magnetic resonance imaging
NAF
Nipple aspirate fluid
OCP
Oral contraceptive pills
PRC
Protocol Review Committee
SAS
Statistical Analysis Software
UCSF
University of California San Francisco

Background

The search for early stage breast cancer, or more importantly, its precursors, is the goal of many researchers hoping to reduce mortality rates from this disease. Current methods of breast cancer early detection include mammography, ultrasound, clinical breast exam (CBE) and breast self-examination (BSE). In addition to these methods, other imaging techniques such as magnetic resonance imaging (MRI) are being explored [1]. Although these cancer detection methods have been used successfully for specific populations, biomarkers that come directly from the breast cells may add to the information obtained from the above-mentioned detection methods. One of the commonly used detection methods, mammography, appears to be less sensitive for younger women (<55 years) [2]. Despite high suspicion of malignancy in mammography, CBE or BSE, a breast cancer diagnosis cannot be made definitively without tissue or cytologic confirmation. More importantly, concentrating on precursors of breast cancer would allow for intervention prior to the development of a malignancy. Intermediate biologic endpoints are also necessary for the evaluation of chemopreventive therapies [3]. Recent studies have indicated that cells from nipple aspirate fluid (NAF) may yield useful information for enhancing breast cancer risk assessment [4]. However, sensitivity has been found to be low in recent studies using other methods of breast fluid analysis for detection of breast cancer, including peri-areolar fine needle aspiration and ductal lavage [5, 6]. Determining which populations will derive the most benefit from the analysis of breast fluid requires additional study of the characteristics of the women most likely to yield fluid resulting in an accurate cytologic diagnosis. Analyzing cells in NAF is a step toward identifying tissue and/or serum based markers of breast cancer risk as 70% of women who develop breast cancer have no identifiable risks factors [7].
In order to utilize NAF as both an adjunct to current breast cancer risk assessment tools and/or for breast cancer early detection, it is important to understand factors influencing the obtainment of adequate fluid samples. Past studies have shown four factors consistently associated with an increased ability to obtain breast fluid; age between 35–50 years, earlier age at menarche, non-Asian compared to Asian ethnicity and a history of lactation [8]. Using a descriptive cross-sectional design, this study examined demographic, menstrual, reproductive and other factors in relation to the ability to obtain NAF in a group of 3043 non-lactating women from the Santa Barbara, California area.

Methods

Subjects

All women were volunteers seen in a private breast clinic by one physician, Dr. Otto Sartorius, who attempted NAF collection on 3413 women. The women came to the clinic for a variety of reasons and NAF was attempted as part of Dr. Sartorius's normal evaluation. The volunteers consisted of women without known breast disease, as well as private clinic patients with known or suspected breast disease [9]. For this paper, all women with breast cancer or women who were diagnosed with breast cancer within six months of their initial clinic visit were excluded from the analysis, reducing the number of eligible subjects to 3043. Dr. Sartorius was a pioneer in the field of breast cancer research, conducting multiple studies in the area of NAF. Upon his death in 1994, Dr. Susan Love was named medical director of his research foundation. The records of Dr. Sartorius are held by The Dr. Susan Love Research Foundation, which granted access to the records to this study's first author, Kimberly Baltzell. Data regarding the obtainment of NAF and medical, reproductive and other factors were abstracted from medical records by a team led by Sandra Tillisch, R.N. in Santa Barbara, California. Human subjects approval was obtained from University of California, San Francisco (UCSF) Committee on Human Research and the UCSF Protocol Review Committee (PRC).

NAF collection

The nipple aspiration technique utilized on this cohort was developed by Dr. Otto Sartorius [9]. Dr Sartorius performed all NAF attempts on this cohort for the specified time period. The aspiration device used was double-chambered. The nipples were scrubbed with 2% acetic acid to remove encrustations, and then dried before attempting aspiration. The aspiration device was placed over the nipple and negative pressure was applied with a syringe attached to the central chamber. If the central chamber was occluded, negative pressure was applied first to the outer chamber. Once fluid was observed, the aspiration device was removed and the fluid was collected in capillary tubes. This procedure was repeated until no additional fluid was expressed. Any visible or measurable quantity of NAF was considered a positive NAF sample. Volume varied from < 1 microliter to greater than 50 microliters. Past studies have shown an increase in cytologic adequacy with an increase in NAF volume [9].

Statistical analysis

Statistical Analysis Software (SAS) [10] version 8.02 was used for all statistical analyses. Distributions of variables from women for whom NAF was obtained were compared to women from whom NAF collection was attempted but not obtained using SAS procedures FREQ or UNIVARIATE and p-values were determined from chi-square and t-tests for discrete and continuous variables, respectively. Logistic regression analysis was used to estimate odds ratios for obtaining versus not obtaining fluid for variables individually adjusted for age and in a multivariate model that included age, marital status, age at menarche, pregnancy history, estrogen use, tranquilizer use and endocrine problems using SAS, PROC LOGISTIC.

Results

The women seen at the clinic were between the ages of 15–89 years at the time of breast fluid extraction. Although ethnicity data were only recorded for 16% of the cohort, the geographic area is predominantly Caucasian. Of the ethnicity information known for 16% of this cohort, 89.1% of those were Caucasian (N = 443). Cohort demographics are listed in Table 1.
Table 1
Demographic, menstrual, reproductive, and other characteristics of women from the Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
Characteristic Variables
N (#)
%
Median
Mean
SE
Continuous
     
   Age (years)
3043
 
43
44.5
0.27
   Height (inches)
2927
 
64.5
64.5
0.05
   Earliest Weight (lbs.)
2921
 
130
136.4
0.49
   Body Mass Index
2910
 
22.3
23.4
0.08
Discrete
     
   Marital Status
     
Married
1833
60.2
   
Single
530
17.4
   
Divorced
307
10.1
   
Widowed
178
5.9
   
No Data
195
6.4
   
   Age at Menarche (yrs)
     
< 10 yrs
25
0.8
   
10 to 12 yrs
945
31.1
   
13 to 14 yrs
1259
41.4
   
> 14 yrs
317
10.4
   
No Data
497
16.3
   
   History of Pregnancy
     
Yes
2155
70.8
   
No
887
29.2
   
Missing
1
0
   
   Breastfed Any Child
     
Yes
1209
39.7
   
No, but history of pregnancy
870
28.6
   
Never pregnant
887
29.2
   
Missing
76
2.5
   
   Menopausal
     
Yes
1328
43.6
   
No
1600
52.6
   
No Data
115
3.8
   
   Age at Menopause (yrs)
     
20 to 29 yrs
98
3.2
7.4*
 
30 to 39 yrs
297
9.8
22.4*
 
40 to 49 yrs
498
16.4
37.5*
 
50 to 59 yrs
401
13.2
30.2*
 
> 59 yrs
6
0.2
0.5*
 
Premenopausal
1600
52.6
   
No Data
143
4.7
   
   Menopause Reason
     
Natural menopause
500
16.4
37.7
Hysterectomy only
419
13.8
31.6
Hysterectomy + 1 ovary
79
2.6
5.9
Hysterectomy + both ovaries
256
8.4
19.3
Both ovaries removed only
2
0.1
0.2
Radiation
3
0.1
0.2
Chemotherapy
2
0.1
0.2
Hysterectomy, ovary unkn
4
0.1
0.3
Premenopausal
1600
52.6
   
No Data
178
5.8
   
   External Estrogen (among menopausal women only n = 1328)
Yes
838
63.1
   
No
466
35.1
   
No Data
24
1.8
   
   Tranquilizer Use
     
Yes
365
12
   
No
2510
82.5
   
No Data
168
5.5
   
   Oral Contraceptive Pills
     
Yes
1580
51.8
   
No
1124
36.9
   
No Data
339
11.1
   
   Endocrine Problems**
508
16.7
   
Yes
2393
78.6
   
No
142
4.7
   
No Data
     
SE, standard error of the Mean
* Percentage is among 1328 menopausal women with 28 missing age at menopause.
Percentage from 1328 menopausal women with 63 missing menopause reason.
** Among women with endocrine problems 61 had diabetes, 21 had hyperthyroidism, 382 had hypothyroidism, and other types of endocrine problems are unknown.
Fluid was obtained from 1314 women (43%) and attempted but not obtained from 1729 women (57%). Overall, the mean age for women who yielded breast fluid was 41.9 years versus 46.5 years for women from whom aspiration was unsuccessfully attempted (p=<.0001). NAF production is lower in women under 30, and then relatively constant for the next 25 years, and then declines in older age women (Figure 1.) Figure 1 highlights the trend in breast fluid production in women by 5-year age intervals. A decrease in the ability to obtain fluid is evident in all categories (premenopausal, natural menopause and all postmenopausal) beginning at approximately age 55.
In both unadjusted and age-adjusted comparisons, fluid was more likely to be obtained from women who were married, had a history of any pregnancy, tranquilizer use, a younger age at menarche, or endocrine problems (defined as hypothyroidism, hyperthyroidism or diabetes). Fluid was less likely to be obtained from women who used exogenous estrogen (Table 3). After multivariate adjustment, women who were married, had a history of pregnancy, tranquilizer use and endocrine problems remained significantly more likely to yield breast fluid, while a younger age at menarche was no longer significantly associated. In addition, menopausal women who took estrogen were less likely to yield fluid than premenopausal women. Adding body mass index (BMI) to the multivariate analysis did not influence significant factors appreciably, and therefore, was excluded from the final analysis. A history of breast-feeding was not significant in any of the analyses.
Table 2
Comparison of continuous variable mean and medians for women from whom fluid was obtained versus not obtained, Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
 
NAF Fluid Obtained
NAF Fluid NOT Obtained
 
Continuous Variables
N (#)
Median
Mean
SE*
N (#)
Median
Mean
SE
t-test p-value
Age (years)
1314
41.0
41.9
0.36
1729
45.0
46.5
0.38
<0.0001
Height (inches)
1249
65.0
64.6
0.07
1678
64.5
64.5
0.07
0.87
Earliest Weight (lbs.)
1242
130.0
134.9
0.75
1679
132.0
137.4
0.64
0.002
Body Mass Index
1239
22.1
23.1
0.12
1671
22.4
23.6
0.11
0.001
* SE, standard error of the Mean
Table 3
Unadjusted, adjusted, and multivariate analyses of factors influencing the ability to obtain nipple aspirate fluid (NAF), Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
 
No NAF Obtained
NAF Obtained
Chi-square
Age-adjusted Odds
Multivariate* adjusted Odds
VARIABLE
N (%)
N (%)
p-value
Ratio
95% CI*
p-value
Ratio
95% CI
p-value
Marital Status
           
No
617 (60.8)
398 (39.2)
         
Yes
988 (53.9)
845 (46.1)
0.0004
1.39
1.19
1.63
<0.0001
1.30
1.06
1.59
0.01
Age at Menarche
           
13 and older
981 (62.3)
595 (37.8)
0.004
1.19
1.01
1.41
0.04
1.18
0.98
1.43
0.08
12 or younger
548 (56.5)
422 (43.5)
         
Pregnancy History
           
Never pregnant
546 (61.6)
341 (38.4)
         
Ever pregnant
1183 (54.9)
972 (45.1)
0.0007
1.66
1.40
1.97
<0.0001
1.55
1.24
1.94
0.0001
Breastfed Children
           
Never Breastfed
483 (55.5)
387 (44.5)
         
Ever Breastfed
663 (54.8)
546 (45.2)
0.76
0.96
0.80
1.15
0.65
    
Menopause
           
No
845 (52.8)
755 (47.2)
         
Yes
838 (63.1)
490 (36.9)
<0.0001
1.04
0.84
1.29
0.73
    
Estrogen Use
           
No
1116 (56.1)
755 (47.2)
         
Yes
580 (63.2)
489 (36.9)
0.02
1.23
1.02
1.48
0.03
    
Menopausal status and Estrogen use
           
Premenopausal women
822 (53.3)
721 (46.7
<0.0001
referent
   
referent
   
Menopausal and NO estrogen
293 (62.9)
173 (37.1)
 
1.00
0.77
1.29
0.99
0.76
0.55
1.04
0.09
Menopausal and estrogen
538 (64.2)
300 (35.8)
 
1.01
0.79
1.28
0.94
0.71
0.52
0.95
0.02
Oral Contraceptive Pills
           
No
715 (63.6)
409 (36.4)
         
Yes
873 (55.3)
707 (44.8)
<0.0001
0.98
0.82
1.17
0.82
    
Tranquilizer Use
           
No
1501 (59.8)
1009 (40.2)
         
Yes
145 (39.7)
220 (60.3)
<0.0001
2.50
2.00
3.15
<0.0001
2.20
1.63
2.98
<0.0001
Endocrine Problems
           
Never
1401 (58.6)
992 (41.5)
         
Ever had
273 (53.7)
235 (46.3)
0.05
1.47
1.21
1.80
0.0001
1.39
1.07
1.81
0.01
* Multivariate model is adjusted for age, marital status, age at menarche, any pregnancy history, the combination of menopausal status and estrogen use, tranquilizer use, and endocrine problems (in the multivariate model N = 2104)
** CI, Confidence interval
Total number of women for whom NAF fluid was not obtained = 1729 (56.8%)
Total number of women for whom NAF fluid was obtained = 1314 (43.2%)
Total number of women, N = 3043

Discussion

This study builds on the work of Wrensch et al. [8] and others in illuminating factors associated with an increased ability to obtain NAF. Wrensch et al.'s work compared findings from 5 previous studies with the findings from a cohort of 1428 women. Four factors were consistently associated with NAF obtainment in the comparison: 1) age 35–55 years, 2) an earlier age at menarche, 3) non-Asian compared to Asian ethnicity and 4) history of lactation. In the present study, younger age was also found to be positively associated with obtaining fluid. This is consistent with findings by Wrensch et al. [8], Petrakis et al. [11], Petrakis et al. [12] and Wnyder et al. [13]. Wrensch et al. [8] suggested that a decline in secretory activity of the breast may explain these findings, rather than the onset of menopause.
Although being married was positively associated in multivariate analysis with increased ability to obtain fluid in the present study, it was examined in only one other comparison study [14] and was not found to be significant. Marital status remained significant in all analyses in the present study, including adjustment for age and a history of pregnancy, discounting the speculation that confounding of marriage with parity and breast-feeding might explain the increased ability to obtain fluid. Given there are no ready biologic reasons to explain this finding, additional study of this variable is warranted.
A previous history of pregnancy was highly significant in the present study in all analyses and this is consistent with findings from Buehring [15] and Petrakis et al. [12]. Previous studies [8, 12, 15], found an increased ability to obtain breast fluid in women with a history of lactation, although this study did not.
In the present study, postmenopausal women who used estrogen were significantly less likely to yield fluid compared with premenopausal women. Menopausal estrogen use was not found to be significant in any of the previous comparison studies [1216] with the exception of Petrakis et al[12], who found that women after age 60 who used estrogen were significantly more likely to yield fluid than women who did not use estrogen over the age of 60. This is in direct contrast to the present study findings; however, this study did not differentiate estrogen users by age, only menopausal status. Given the lack of significant findings in other similar studies, it appears that exogenous estrogen use in post-menopausal women may not be an important determinant of ability to obtain breast fluid. In fact, in the present study, the inverse was found. In addition, the present study found that there were no significant differences between women who were post-menopausal and did not take estrogen and premenopausal women after adjusting for age. It seems likely that endogenous reproductive and menstrual hormones are partly responsible for the greater ability to obtain NAF in younger versus older women or in women with intact ovaries versus those with bilateral oophorectomy, given recent studies showing reduced NAF yield in women undergoing bilateral salpingo-oophorectomy (BSO), making rates of NAF production for premenopausal women undergoing BSO similar to the rates of post-menopausal women [17]. However, at a certain age (which likely varies between women), aspects of senescence other than declining endogenous hormones also might influence breast physiology, the production of NAF, and the ability to obtain it. Greater understanding of these factors would be necessary to explain why exogenous estrogens do not appear to increase ability to obtain NAF.
Tranquilizer use was positively associated with an increased ability to yield breast fluid; however, this factor was not found to be significant in the only comparison study that considered this factor [12]. Sartorius [18] suggested that some tranquilizers appear to increase breast secretions but did not formally study the effects for statistical significance. Looking at the pharmaceutical properties of tranquilizers will be necessary to further ascertain the role of this type of medication in increasing breast fluid production. The tranquilizers used during this period were probably different from tranquilizers that are used currently; therefore, these findings may not be applicable to today's women. In addition, tranquilizers may alter the protein and cellular content of NAF, affecting the fluid biology and its diagnostic value.
The endocrine disorders studied from the Sartorius cohort produced conflicting findings, given that the disorders included are diabetes and both hyper- and hypo-thyroidism. Wynder et al. [14] studied similar endocrine disorders but did not find any significant associations with an increased breast fluid yield.
Factors which were not found to be significantly associated with breast fluid yield in the present study which are consistent with lack of significance in other studies include menopausal status and oral contraceptive use. Only one study found oral contraceptive use to be significantly related to an increased ability to obtain breast fluid [15]. The following significant findings in the present study; marital status, tranquilizer use and a history of endocrine disorders, have not been widely examined in other nipple aspirate fluid studies.
While the Sartorius cohort represents a unique group from which to examine important factors related to obtaining NAF, the data do have some limitations. Most notable is that in contrast to other studies, a structured questionnaire was not used to obtain information on potentially relevant factors. Instead, the data were obtained from medical record abstraction. It is possible that there may have been some inconsistency over time in how or whether factors were recorded in the medical records. Also, the cohort included women with suspected breast disease; therefore, the ability to generalize the findings may be limited. All available information regarding the characteristics of the cohort was disclosed in Table 1. Differences between studies in collection of risk factor data and characteristics of the women themselves may explain some of the inconsistencies between studies. In addition, Dr Sartorius was the sole collector of NAF in this study. Since 1990, the end point for the Sartorius study data collection, other NAF collection devices have been developed and different collection techniques have been tried. The technique mostly commonly used now includes applying warm compresses to the breast, gentle massage and the use of an aspiration cup (FirstCyte aspirator; Cytyc Corporation, Marlborough, MA) [19]. NAF collection rates may be influenced by the device used, the technique used, as well as the person performing the NAF collection. In a 1990 meta-analysis, differences were noted in maximum pressure used, duration of pressure and definition of secretor status [8]. All of these factors impact the percentage of successful NAF attempts reported. The quantity of the fluid present, the characteristics of the duct and nipple and the proficiency of the investigator collecting the specimen (which appears to increase after > 30 different individual NAF collections) also influence the success rates reported [4]. Regardless of technique used, collection rates are consistently higher in younger women.

Conclusion

Taken together, this and other studies suggest that age is the most consistent factor affecting obtainment of breast fluid. Wrensch et al. [4, 8] obtained NAF from 42% of women less than 50 years of age. This study found NAF was obtained from roughly half of all women under 50 years, decreasing markedly after age 50 (49% and 26% respectively). Nipple aspirate fluid analysis may hold promise for younger women who do not fully benefit from current breast cancer risk assessment tools and/or breast cancer detection methods. More studies evaluating the feasibility of examining breast cells from NAF, as well as clarifying the most likely population for its use, are necessary.

Acknowledgements

This work was made possible through the cooperation of The Dr. Susan Love Research Foundation. Dr. Marylin Dodd, UCSF Department of Physiological Nursing and Dr. John Wiencke, UCSF Department of Neurological Surgery provided academic guidance to the first author throughout the project.
Funding for the study was obtained from the Department of Defense, Clinical Research Nurse Award, # DAMD17-03-1-0354.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

KB conceived of the study and set up the design and coordination of the research team. She also reviewed and interpreted all statistical analyses and drafted the original manuscript. MW participated in the study design and helped to draft the manuscript, including reviewing data analysis and providing assistance with revisions. JS performed statistical analyses. All authors have read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Hollingsworth AB, Stough R: The emerging role of breast magnetic resonance imaging. The Journal of the Oklahoma State Medical Association. 2003, 96: 299-307.PubMed Hollingsworth AB, Stough R: The emerging role of breast magnetic resonance imaging. The Journal of the Oklahoma State Medical Association. 2003, 96: 299-307.PubMed
2.
Zurück zum Zitat Kolb T, Lichy J, Newhouse J: Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002, 225: 165-175.CrossRefPubMed Kolb T, Lichy J, Newhouse J: Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002, 225: 165-175.CrossRefPubMed
3.
Zurück zum Zitat Daly M, Ross E: Predicting breast cancer: the search for a model. Journal of the National Cancer Institute. 2000, 92: 1196-1197. 10.1093/jnci/92.15.1196.CrossRefPubMed Daly M, Ross E: Predicting breast cancer: the search for a model. Journal of the National Cancer Institute. 2000, 92: 1196-1197. 10.1093/jnci/92.15.1196.CrossRefPubMed
4.
Zurück zum Zitat Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M: Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. Journal of the National Cancer Institute. 2001, 93: 1791-1798. 10.1093/jnci/93.23.1791.CrossRefPubMed Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M: Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. Journal of the National Cancer Institute. 2001, 93: 1791-1798. 10.1093/jnci/93.23.1791.CrossRefPubMed
5.
Zurück zum Zitat Khan SA, Wiley EL, Rodriquez N, Baird C, Ramakrishnan R, Nayar R, Bryk M, Bethke K, Staradub VL, Wolfman J, Rademaker A, Ljung BM, Morrow M: Ductal lavage findings in women with known breast cancer undergoing mastectomy. Journal of the National Cancer Institute. 2004, 96: 1510-1517.CrossRefPubMed Khan SA, Wiley EL, Rodriquez N, Baird C, Ramakrishnan R, Nayar R, Bryk M, Bethke K, Staradub VL, Wolfman J, Rademaker A, Ljung BM, Morrow M: Ductal lavage findings in women with known breast cancer undergoing mastectomy. Journal of the National Cancer Institute. 2004, 96: 1510-1517.CrossRefPubMed
6.
Zurück zum Zitat Fabian CJ, Kimler BF, Mayo MS: Ductal lavage for early detection - what doesn't come out in the wash. Journal of the National Cancer Institute. 2004, 96: 1488-1489.CrossRefPubMed Fabian CJ, Kimler BF, Mayo MS: Ductal lavage for early detection - what doesn't come out in the wash. Journal of the National Cancer Institute. 2004, 96: 1488-1489.CrossRefPubMed
7.
Zurück zum Zitat Hollingsworth AB, Nall S, Dill D: The evolution of breast cancer risk assessment. Journal of the Oklahoma State Medical Association. 2002, 95: 639-644.PubMed Hollingsworth AB, Nall S, Dill D: The evolution of breast cancer risk assessment. Journal of the Oklahoma State Medical Association. 2002, 95: 639-644.PubMed
8.
Zurück zum Zitat Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, Hauck WW: Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Research and Treatment. 1990, 15: 39-51. 10.1007/BF01811888.CrossRefPubMed Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, Hauck WW: Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Research and Treatment. 1990, 15: 39-51. 10.1007/BF01811888.CrossRefPubMed
9.
Zurück zum Zitat Sartorius O, Smith H, Morris P, Benedict D, Friesen L: Cytologic evaluation of breast fluid in the detection of breast disease. Journal of the National Cancer Institute. 1977, 59: 1073-1078.PubMed Sartorius O, Smith H, Morris P, Benedict D, Friesen L: Cytologic evaluation of breast fluid in the detection of breast disease. Journal of the National Cancer Institute. 1977, 59: 1073-1078.PubMed
10.
Zurück zum Zitat SAS Institute: SAS Procedures Guide. 1990, Cary, N.C., SAS Institute, 6 SAS Institute: SAS Procedures Guide. 1990, Cary, N.C., SAS Institute, 6
11.
Zurück zum Zitat Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F: Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. Journal of the National Cancer Institute. 1975, 54: 829-834.PubMed Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F: Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. Journal of the National Cancer Institute. 1975, 54: 829-834.PubMed
12.
Zurück zum Zitat Petrakis NL, Ernster VL, Sack S, King EB, Schweitzer R, Hunt T, King M: Epidemiology of breast fluid secretion: association with breast cancer risk factors and cerumen type. Journal of the National Cancer Institute. 1981, 67: 277-284.PubMed Petrakis NL, Ernster VL, Sack S, King EB, Schweitzer R, Hunt T, King M: Epidemiology of breast fluid secretion: association with breast cancer risk factors and cerumen type. Journal of the National Cancer Institute. 1981, 67: 277-284.PubMed
13.
Zurück zum Zitat Wynder E, Lahti H, Laakso K, Cheng SL, DeBevoise S, Rose D: Nipple aspirates of breast fluid and the epidemiology of breast disease. Cancer. 1985, 56: 1473-1478. 10.1002/1097-0142(19850915)56:6<1473::AID-CNCR2820560642>3.0.CO;2-M.CrossRefPubMed Wynder E, Lahti H, Laakso K, Cheng SL, DeBevoise S, Rose D: Nipple aspirates of breast fluid and the epidemiology of breast disease. Cancer. 1985, 56: 1473-1478. 10.1002/1097-0142(19850915)56:6<1473::AID-CNCR2820560642>3.0.CO;2-M.CrossRefPubMed
14.
Zurück zum Zitat Wynder E, Hill P, Laakso K, Littner R, Kettunen K: Breast secretion in Finnish women: A metabolic epidemiologic study. Cancer. 1981, 47: 1444-1450. 10.1002/1097-0142(19810315)47:6<1444::AID-CNCR2820470634>3.0.CO;2-A.CrossRefPubMed Wynder E, Hill P, Laakso K, Littner R, Kettunen K: Breast secretion in Finnish women: A metabolic epidemiologic study. Cancer. 1981, 47: 1444-1450. 10.1002/1097-0142(19810315)47:6<1444::AID-CNCR2820470634>3.0.CO;2-A.CrossRefPubMed
15.
Zurück zum Zitat Buehring G: Screening for breast atypias using exfoliative cytology. Cancer. 1979, 43: 1788-1799. 10.1002/1097-0142(197905)43:5<1788::AID-CNCR2820430532>3.0.CO;2-Z.CrossRefPubMed Buehring G: Screening for breast atypias using exfoliative cytology. Cancer. 1979, 43: 1788-1799. 10.1002/1097-0142(197905)43:5<1788::AID-CNCR2820430532>3.0.CO;2-Z.CrossRefPubMed
16.
Zurück zum Zitat Sharma P, Klemp JR, Simonsen M, Welsko C, Zalles CM, Kimler BF, Fabian CJ: Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Breast Cancer Research and Treatment. 2004, 87: 59-64. 10.1023/B:BREA.0000041582.11586.d3.CrossRefPubMed Sharma P, Klemp JR, Simonsen M, Welsko C, Zalles CM, Kimler BF, Fabian CJ: Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Breast Cancer Research and Treatment. 2004, 87: 59-64. 10.1023/B:BREA.0000041582.11586.d3.CrossRefPubMed
17.
Zurück zum Zitat Higgins S, Matloff E, Rimm D, Dziura J, Haffty BG, King BL: Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Breast Cancer Research and Treatment. 2005, 7: 1017-1022.CrossRef Higgins S, Matloff E, Rimm D, Dziura J, Haffty BG, King BL: Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Breast Cancer Research and Treatment. 2005, 7: 1017-1022.CrossRef
18.
Zurück zum Zitat Sartorius O: Breast fluid cells help in early cancer detection. Journal of the American Medical Association. 1973, 224: 823-827. Sartorius O: Breast fluid cells help in early cancer detection. Journal of the American Medical Association. 1973, 224: 823-827.
19.
Zurück zum Zitat Dua S, Isacke C, Gui G: The intraductal approach to breast cancer biomarker discovery. Journal of Clinical Oncology. 2006, 24: 1209-1216. 10.1200/JCO.2005.04.1830.CrossRefPubMed Dua S, Isacke C, Gui G: The intraductal approach to breast cancer biomarker discovery. Journal of Clinical Oncology. 2006, 24: 1209-1216. 10.1200/JCO.2005.04.1830.CrossRefPubMed
Metadaten
Titel
A descriptive study of variables associated with obtaining nipple aspirate fluid in a cohort of non-lactating women
verfasst von
Kimberly A Baltzell
Margaret Wrensch
Jennette D Sison
Publikationsdatum
01.12.2006
Verlag
BioMed Central
Erschienen in
BMC Women's Health / Ausgabe 1/2006
Elektronische ISSN: 1472-6874
DOI
https://doi.org/10.1186/1472-6874-6-15

Weitere Artikel der Ausgabe 1/2006

BMC Women's Health 1/2006 Zur Ausgabe

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.